Investigation on movement disorders represents an important research interest at the Neurocenter of Southern Switzerland.
The priority of translational research efforts currently relies on the pathogenesis and potential treatment of dyskinesias, involuntary movements that develop in the course of the long-term levodopa treatment of patients with Parkinson's Disease (PD). In addition, a database of patients with movement disorders in Ticino was set up and is used for the performance of epidemiological and clinical studies and an ambitious translational research project using skin biopsy to diagnose Parkinson’s Disease is ongoing.
Group leader: Prof. Alain Kälin, MD
Group leader: Claudio Städler, MD
Group leader: Salvatore Galati, MD PD
